232 related articles for article (PubMed ID: 10893374)
1. Function and composition of pulmonary surfactant and surfactant-derived fatty acid profiles are altered in young adults with cystic fibrosis.
Meyer KC; Sharma A; Brown R; Weatherly M; Moya FR; Lewandoski J; Zimmerman JJ
Chest; 2000 Jul; 118(1):164-74. PubMed ID: 10893374
[TBL] [Abstract][Full Text] [Related]
2. Lung surfactant in a cystic fibrosis animal model: increased alveolar phospholipid pool size without altered composition and surface tension function in cftrm1HGU/m1HGU mice.
Bernhard W; Wang JY; Tschernig T; Tümmler B; Hedrich HJ; von der Hardt H
Thorax; 1997 Aug; 52(8):723-30. PubMed ID: 9337833
[TBL] [Abstract][Full Text] [Related]
3. Surfactant composition in infants and young children with cystic fibrosis.
Hull J; South M; Phelan P; Grimwood K
Am J Respir Crit Care Med; 1997 Jul; 156(1):161-5. PubMed ID: 9230741
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary surfactant in patients with Pneumocystis pneumonia and acquired immunodeficiency syndrome.
Schmidt R; Markart P; Ruppert C; Temmesfeld B; Nass R; Lohmeyer J; Seeger W; Günther A
Crit Care Med; 2006 Sep; 34(9):2370-6. PubMed ID: 16849999
[TBL] [Abstract][Full Text] [Related]
5. Surfactant protein A and other bronchoalveolar lavage fluid proteins are altered in cystic fibrosis.
von Bredow C; Birrer P; Griese M
Eur Respir J; 2001 Apr; 17(4):716-22. PubMed ID: 11401069
[TBL] [Abstract][Full Text] [Related]
6. Conductive airway surfactant: surface-tension function, biochemical composition, and possible alveolar origin.
Bernhard W; Haagsman HP; Tschernig T; Poets CF; Postle AD; van Eijk ME; von der Hardt H
Am J Respir Cell Mol Biol; 1997 Jul; 17(1):41-50. PubMed ID: 9224208
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary surfactant in cystic fibrosis.
Griese M; Birrer P; Demirsoy A
Eur Respir J; 1997 Sep; 10(9):1983-8. PubMed ID: 9311489
[TBL] [Abstract][Full Text] [Related]
8. Altered phospholipid composition and aggregate structure of lung surfactant is associated with impaired lung function in young children with respiratory infections.
Mander A; Langton-Hewer S; Bernhard W; Warner JO; Postle AD
Am J Respir Cell Mol Biol; 2002 Dec; 27(6):714-21. PubMed ID: 12444031
[TBL] [Abstract][Full Text] [Related]
9. Bronchoalveolar lavage fluid surfactant protein-A and surfactant protein-D are inversely related to inflammation in early cystic fibrosis.
Noah TL; Murphy PC; Alink JJ; Leigh MW; Hull WM; Stahlman MT; Whitsett JA
Am J Respir Crit Care Med; 2003 Sep; 168(6):685-91. PubMed ID: 12829455
[TBL] [Abstract][Full Text] [Related]
10. Surfactant subtype conversion is related to loss of surfactant apoprotein B and surface activity in large surfactant aggregates. Experimental and clinical studies.
Günther A; Schmidt R; Feustel A; Meier U; Pucker C; Ermert M; Seeger W
Am J Respir Crit Care Med; 1999 Jan; 159(1):244-51. PubMed ID: 9872845
[TBL] [Abstract][Full Text] [Related]
11. Surfactant abnormalities in idiopathic pulmonary fibrosis, hypersensitivity pneumonitis and sarcoidosis.
Günther A; Schmidt R; Nix F; Yabut-Perez M; Guth C; Rosseau S; Siebert C; Grimminger F; Morr H; Velcovsky HG; Seeger W
Eur Respir J; 1999 Sep; 14(3):565-73. PubMed ID: 10543276
[TBL] [Abstract][Full Text] [Related]
12. Deficient hydrophilic lung surfactant proteins A and D with normal surfactant phospholipid molecular species in cystic fibrosis.
Postle AD; Mander A; Reid KB; Wang JY; Wright SM; Moustaki M; Warner JO
Am J Respir Cell Mol Biol; 1999 Jan; 20(1):90-8. PubMed ID: 9870921
[TBL] [Abstract][Full Text] [Related]
13. Degradation of annexin I in bronchoalveolar lavage fluid from patients with cystic fibrosis.
Tsao FH; Meyer KC; Chen X; Rosenthal NS; Hu J
Am J Respir Cell Mol Biol; 1998 Jan; 18(1):120-8. PubMed ID: 9448053
[TBL] [Abstract][Full Text] [Related]
14. Changes in biochemical and biophysical surfactant properties with cardiopulmonary bypass in children.
Friedrich B; Schmidt R; Reiss I; Günther A; Seeger W; Müller M; Thul J; Schranz D; Gortner L
Crit Care Med; 2003 Jan; 31(1):284-90. PubMed ID: 12545030
[TBL] [Abstract][Full Text] [Related]
15. Altered airway surfactant phospholipid composition and reduced lung function in asthma.
Wright SM; Hockey PM; Enhorning G; Strong P; Reid KB; Holgate ST; Djukanovic R; Postle AD
J Appl Physiol (1985); 2000 Oct; 89(4):1283-92. PubMed ID: 11007560
[TBL] [Abstract][Full Text] [Related]
16. Local effect of lung contusion on lung surfactant composition in multiple trauma patients.
Aufmkolk M; Fischer R; Voggenreiter G; Kleinschmidt C; Schmit-Neuerburg KP; Obertacke U
Crit Care Med; 1999 Aug; 27(8):1441-6. PubMed ID: 10470747
[TBL] [Abstract][Full Text] [Related]
17. Biophysical inhibition of synthetic vs. naturally-derived pulmonary surfactant preparations by polymeric nanoparticles.
Beck-Broichsitter M; Ruppert C; Schmehl T; Günther A; Seeger W
Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):474-81. PubMed ID: 24184425
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor in bronchoalveolar lavage from normal subjects and patients with diffuse parenchymal lung disease.
Meyer KC; Cardoni A; Xiang ZZ
J Lab Clin Med; 2000 Apr; 135(4):332-8. PubMed ID: 10779049
[TBL] [Abstract][Full Text] [Related]
19. Purification and biochemical characterization of pulmonary surfactant protein A of horses.
Hobo S; Ogasawara Y; Kuroki Y; Akino T; Yoshihara T
Am J Vet Res; 1999 Feb; 60(2):169-73. PubMed ID: 10048546
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary surfactant activity is impaired in lung transplant recipients.
Hohlfeld JM; Tiryaki E; Hamm H; Hoymann HG; Krug N; Haverich A; Fabel H
Am J Respir Crit Care Med; 1998 Sep; 158(3):706-12. PubMed ID: 9730994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
